Criterios clínicos y de laboratorio para el uso de los inhibidores SGLT2 en la enfermedad renal crónica.

Chronic kidney disease (CKD) is characterized by a sustained reduction in glomerular filtration rate (GFR) and/or by markers of kidney damage. Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) have shown renoprotective effects by inducing glycosuria through the inhibition of glucose reabsorpti...

• Главный автор: Caisatoa Cabrera, Estefanía Dayana (author)
• Другие авторы: Carvajal Trujillo, Valeria Michelle (author)
• Формат: bachelorThesis
• Язык: spa
• Опубликовано: 2025
• Предметы: Enfermedad renal crónica; iSGLT2; Tasa de filtración glomerular; Albuminuria
• Online-ссылка: http://dspace.unach.edu.ec/handle/51000/15643